指南与共识哮喘慢阻肺间质性肺疾病

优化呼吸系统疾病实验研究:ERS声明

Optimising experimental research in respiratory diseases: an ERS statement.
指南 / 共识 · Eur Respir J · 2018-05-17

欧洲呼吸学会工作组发布声明,针对哮喘、慢阻肺、肺纤维化、肺部感染、急性肺损伤和肺动脉高压的实验模型提出研究建议,强调使用多种模型验证结果、增加人体组织可及性以及标准化操作和数据质量的重要性。

要点

  • 建议使用多种模型验证实验结果的有效性
  • 强调增加人体组织可及性和标准化操作程序
  • 关注实验研究的伦理、物种、性别、年龄及基因编辑等通用问题

核心结论

  • 工作组强调使用多种模型以增强结果有效性,需增加人体组织可及性,并重视标准化操作程序和数据质量。

研究设计与样本

  • 欧洲呼吸学会工作组通过呼吸科学家深入讨论,发布关于肺疾病模型的研究建议声明,并概述现有模型文献。

主要发现

  • 声明涵盖实验研究通用问题(伦理、物种、性别、年龄、离体和体外模型、基因编辑),并包括哮喘、慢阻肺、肺纤维化、肺部感染、急性肺损伤和肺动脉高压的建模研究建议。

临床怎么用

  • 临床研究者可参考声明中的建议优化实验研究设计,促进资源高效利用并减少动物使用数量。

局限性

  • 原文未报告具体文献检索范围或系统评价方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Experimental models are critical for the understanding of lung health and disease and are indispensable for drug development. However, the pathogenetic and clinical relevance of the models is often unclear. Further, the use of animals in biomedical research is controversial from an ethical perspective.The objective of this task force was to issue a statement with research recommendations about lung disease models by facilitating in-depth discussions between respiratory scientists, and to provide an overview of the literature on the available models. Focus was put on their specific benefits and limitations. This will result in more efficient use of resources and greater reduction in the numbers of animals employed, thereby enhancing the ethical standards and translational capacity of experimental research.The task force statement addresses general issues of experimental research (ethics, species, sex, age, ex vivo and in vitro models, gene editing). The statement also includes research recommendations on modelling asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, lung infections, acute lung injury and pulmonary hypertension.The task force stressed the importance of using multiple models to strengthen validity of results, the need to increase the availability of human tissues and the importance of standard operating procedures and data quality.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Bonniaud P, Fabre A, Frossard N, et al. Optimising experimental research in respiratory diseases: an ERS statement. Eur Respir J. 2018. PMID: 29773606. doi:10.1183/13993003.02133-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。